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History of Caffeine 
Caffeine derived from natural sources has been consumed 
and enjoyed by people throughout the world for centuries and 
is currently the most widespread and indiscriminately used 
drug available to consumers of all ages (1). This fact 
creates the need for more research regarding the health 
risks and deleterious effects encountered by regular 
consumers of caffeine. The general public usually 
acknowledges the xanthine derivative as an ingredient in 
coffee, tea, and soft drinks (Table I). A 12 ounce can of 
many carbonated beverages contains about 30-50 milligrams 
caffeine, 5 ounces instant coffee contains approximately 60 
mg., the same size serving of brewed coffee contains about 
110 mg., and 5 ounces of brewed tea contains about 30 mg. of 
a similar xanthine (1). Coffee accounts for over 80% of 
caffeine intake in adults (2). The public may be unaware, 
however, of other products containing xanthines such as; 
chocolate, gelatins, puddings, frozen dairy products and the 
largest being medication. According to the FDA, about 1000 
prescription drug products and about 2000 over the counter 
non-prescription (OTC) drug products contain caffeine (3). 
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Typical prescription drugs range between 30-100 mg. caffeine 
per tablet or capsule. Caffeine levels in OTC 
drugs also vary widely (typically from 15-200 mg. per tablet 
or capsule) and not only depend on the type of product but 
also the brand involved. 
Since the products containing caffeine are so diverse, 
most adults are not aware that their average daily 
consumption may be as high as 250 mg., which is considered 
to be a large dose (1). The Market Research Corporation of 
America (MRCA) Survey data revealed the mean daily caffeine 
intake from all sources for adults to be 2.6 milligrams per 
kilogram of body weight (mg./kg. bwt.). For example, for a 
150 pound person this would be approximately 177 mg. (or 
about two cups of coffee). Doses of 50-200 mg. of caffeine 
result in increased alertness, decreased drowsiness, and 
lessened fatigue. However, doses in the range of 200-500 
mg. may produce headache, tremors, nervousness, and 
irritability. MRCA Survey data have calculated the mean 
estimated intake in the lOth percentile of adult consumers 
to be 7.0 mg./kg. body weight (4). According to another 
source, the daily consumption of caffeine in the U.S. is 
estimated to be 206 mg. (5). Heavy consumption of caffeine 
is known to cause symptoms collectively know as caffeineism. 
Yet, these symptoms are indistinguishable from a classic 
description of anxiety attack (6). Specifically, the 
patient may exhibit symptoms of nervousness, irritability, 
tremulousness, muscle twitching, insomnia, sensory 
disturbances, rapid breathing, palpations, flushing, 
arrhythmias, and gastrointestinal disturbances (7). 
A need exists for research regarding the effects of 
caffeine on hand steadiness, tracing ability, kinesthetic 
sense and manual dexterity in those individuals who are 
regular caffeine consumers. Many occupations today demand 
precision and the performance of simple yet delicate motor 
skills. If caffeine should affect these motor skills in 
heavy consumers, employees as well as employers have the 
right to know this information. 
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TABLE I 
CAFFEINE CONTENT IN BEVERAGES, DRUGS, 
& MISCELLANEOUS PRODUCTS 
CAFFEINE CONTENT OF SOFT DRINKS (MG. CAFFEINE IN 12 OZ.) 
*Source 
BRAND .l 2 3 ± 
Sugar Free Mr. Pibb 58.8 58.0 
Mountain Dew 54.0 54.0 54.7 49.0 
Mellow Yellow 52.8 52.0 
Tab 46.8 46.0 49.4 45.0 
Coca-Cola (old and new) 45.6 46.0 64.7 42.0 
Diet Coke 44.4 46.0 
Shasta Cola 44.0 44.0 
Shasta Cherry Cola 44.4 44.0 
Shasta Diet Cola 40.8 44.0 
Mr. Pibb 40.8 40.8 57.0 
Dr Pepper 39.6 40.8 60.9 61.0 
Sugar Free Dr. Pepper 39.6 40.8 54.2 
Big Red 38.4 30.8 
Sugar Free Big Red 38.4 
Pepsi 38.4 38.4 43.1 35.0 
Diet Pepsi 36.0 36.0 34.0 
RC Cola 36.0 36.0 33.7 36.0 
Diet Rite 36.0 31.7 
Diet RC 33.0 
*Source 
1. Institute of Food Technologists (IFT), April 1983, 
based on data from National Soft Drink Association, 
Washington, D.C. 
2. Soft Drink Companies 
3. Bunker, L. and McWilliams, M. (1979). "Caffeine 
Content of Common Beverages." Journal of The 
American Dietetic Association, 74: 28-32. 
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4. Soft Drink Companies and the Journal of the American 
Dietetic Association. 
CAFFEINE CONTENT IN COFFEE (MG. IN 5 OZ.) 






















1. FDA, Food Additive Chemistry Evaluation Branch. 
2. Journal of the American Dietetic Association. 
3. FDA, Food Additive Chemistry Branch, based on 
evaluations of existing literature on caffeine levels. 
CAFFEINE CONTENT IN TEA (MG. IN 5 OZ) 
Brewed 











1. FDA, Food Additive Chemistry Evaluation Branch. 
2. Journal of the American Dietetic Association. 
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TABLE I (Continued) 
CAFFEINE CONTENT IN NON-PRESCRIPTION DRUGS 












1. FDA's National Center for Drugs and Biologics. 





























1. Physician's Desk Reference and Pharmaceutical Companies 
TABLE I (Continued) 
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1. FDA, Food Additive Chemistry Evaluation Branch. 
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Properties of Caffeine 
To understand the effects of caffeine on hand 
steadiness, tracing ability, kinesthetic sense, and manual 
dexterity one must possess general knowledge of the chemical 
makeup of the drug and it's effects on various organ systems 
in the body. Caffeine is a methylxanthine whose chemical 
structure facilitates its use and dispersion within the 
central nervous system (CNS) of the body. Caffeine is 
defined structurally as a 1, 3, 7-trimethyl xanthine (Figure 
I). The drug forms readily stable combinations with sodium 
benzoate and sodium salicylate, which are used in oral and 
intramuscular medicinal applications, and is decomposed by 
hot alkalies and reacts with chlorine (8). Pure caffeine is 
odorless, has a distinctly bitter taste and is stable at 
temperature, pH, and salt concentrations normally 
encountered in food processing (1). 
The majority of neuropharmalogical information on 
caffeine is limited to effects related to formation and 
release of neurotransmitters (9), specifically the 
catecholamines in the autonomic nervous system. Caffeine is 
moderately soluble in water, yet it is hydrophobic enough to 
easily pass through biological membranes. It passes through 
biological membranes mostly by passive diffusion (1). 
Caffeine is absorbed rapidly from the gastrointestinal 
tract and reaches peak plasma levels in approximately one 
hour after oral ingestion (7). It quickly passes through 
the blood brain barrier to act directly on medullary, vagal, 
v 
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and vasomotor centers (10). It can move then into various 
tissues in proportion to their water content; tissue 
response is proportional to caffeine content (11). Caffeine 
acts as a stimulant to the CNS, a diuretic on the kidneys, a 
stimulant to cardiac muscles, and a relaxant to smooth 
muscle (7). 
The average half life of caffeine is 3.5 hours (15% 
metabolism rate) and may be affected by hormone interaction. 
Women utilizing oral contraceptive steroids have a decreased 
capacity to eliminate caffeine from the body (12). Syed 
(13) states that oral contraceptives taken in conjunction 
with caffeine increases the half life of caffeine threefold. 
10 
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Figure 1. Chemical Structure of Caffeine 
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Effects of Caffeine 
Some studies indicate that prolonged habitual use of 
caffeine may produce hazardous medical and physical 
complications. In women, caffeine has been implicated in 
the development of benign fibrocystic disease of the breast 
(14). Caffeine dramatically increases the vasoactive 
constrictive properties that alter uterine and placental 
blood flow patterns. High caffeine intake (600 mg. per day) 
is associated in a greater incidence of fetal loss (15). 
Nursing mothers inadvertently may cause biological trauma to 
their offspring through their ability to pass caffeine on 
via their milk (16). The FDA has advised pregnant women to 
eliminate completely or limit their intake of products 
containing caffeine (17). 
Prineas and associates (18) demonstrated a link between 
premature ventricular contractions (PVC) and heavy coffee or 
tea consumption in 7252 men. The association remained 
significant after adjustment for age, known coronary risk 
factors, simultaneous food consumption, duration of sleep 
and alcohol consumption. Their results suggested that the 
consumption level of tea and coffee required to induce or 
increase the prevalence of PVC's is high (greater than 9 
cups of coffee per day). 
Very low concentrations (ie. within the range of 
caffeine levels commonly found in human plasma) can block 
the physiological effects of the purine nucleoside adenosine 
(19). Caffeine may produce it's effects by acting as an 
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antagonist of the influences of endogenous adenosine upon 
neural, cardiovascular, respiratory, renal, and other 
physiological processes (21). Adenosine's actions are 
mediated through stereospecific "receptors" on the 
extracellular surfaces of cell membranes. Caffeine competes 
with adenosine and certain pharmacological active adenosine 
derivatives for occupancy of these receptor sites; (20) 
adenosine and caffeine have certain structural similarities. 
Endogenous adenosine exerts a tonic sedative effect on the 
brain so it's blockade produces, as a net result, caffeine's 
familiar apparent stimulatory effect (22). 
Boulenger (23) found that when rats were given daily 
caffeine in their food for several weeks they undergo a 
compensatory increase in the number of adenosine receptors 
in their brains. It is possible that some of the symptoms 
of caffeine withdrawal (such as headache and fatigue) may 
reflect an enhanced sensitivity to endogenous adenosine. 
Caffeine is used as an ingredient in several headache 
remedies, wherein it's beneficial effect may result from 
it's capacity to constrict cerebral arteries; (24) adenosine 
is a potent dilator of the cerebral vasculature (25). 
Fisher et al. (26) concluded that habitual caffeine 
users appeared to be desensitized or to have developed a 
tolerance to caffeine that was evident at both rest and 
exercise. Prior to participation in Fisher's study all 
subjects were screened for habitual caffeine intake by 
recording daily caffeine intake over a consecutive five day 
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period. Furthermore, four days (or more) of withdrawal from 
caffeine resensitizes an individual to caffeine's 
physiological effect. 
Some researchers have suggested that caffeine impairs 
hand steadiness and causes tremors (7,37,38,39). However, 
Goldstein, Kaizer, and Warren (46) found no impairment of 
coordination as a result of 150 mg. and 300 mg. of caffeine. 
No available investigations have explored the dose response 
curve as it applies to hand steadiness or manual dexterity. 
Purpose of the Study 
The intent of this investigation was to examine the 
effects of two levels of caffeine (2.5 mg./kg. bwt. and 5.0 
mg./kg. bwt.) and a placebo of lactose powder on hand 
steadiness, tracing ability, kinesthetic sense, and manual 
dexterity on regular caffeine consumers. 
Delimitations 
1. There will be eight subjects used in this study. 
2. All subjects were above the national average (206 
mg.) in the amount of caffeine consumed per day. 
3. All subjects were apparently healthy females, 
ages 20 to 26, from a rural midwestern college 
town. 
4. There were two levels of caffeine administered, 
2.5 mg./kg. bwt. and 5.0 mg./kg. bwt. 
5. The subjects who participated in this 
investigation were not randomly selected. 
Limitations 
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1. Good health was determined by medical questionnaire 
and blood pressure only. 
2. There may have been individual sensitivity to 
caffeine. 
Assumptions 
1. Subjects correctly followed all instructions. 
2. Subjects consumed the caffeine capsule. 
3. Subjects were honest in their estimates of caffeine 
ingestion prior to the study. 
4. Subjects fasted from caffeine 24 hours prior to 
each testing session and from food five hours prior 
to each testing session. 
Hypotheses 
The following hypotheses will be examined in this 
investigation: 
HOl: There will be no difference between pre- and 
post-test scores on hand steadiness after consumption of 0 
mg/kg bwt. caffeine in regular caffeine consumers. 
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H02: There will be no difference between pre- and 
post-test scores on hand steadiness after consumption of 2.5 
mg/kg bwt. in regular caffeine consumers. 
H03: There will be no difference between pre- and 
post-test scores on hand steadiness after consumption of 5.0 
mg/kg bwt. in regular caffeine consumers. 
H04: There will be no difference between pre- and 
post-test scores on tracing after consumption of 0 mg/kg 
bwt. caffeine in regular caffeine consumers. 
H05: There will be no difference between pre- and 
post-test scores on tracing after consumption of 2.5 mg/kg 
bwt. caffeine in regular caffeine consumers. 
H06: There will be no difference between pre- and post-
test scores on tracing after consumption of 5.0 mg/kg bwt 
caffeine in regular caffeine consumers. 
H07: There will be no difference between pre- and 
post-test scores on kinesthetic sense after consumption of 0 
mg/kg bwt. caffeine in regular caffeine consumers. 
HOB: There will be no difference between pre- and 
post-test scores on kinesthetic sense after consumption of 
2.5 mg/kg bwt. caffeine in regular caffeine consumers. 
H09: There will be no difference between pre- and 
post-test scores on kinesthetic sense after consumption of 
5.0 mg/kg bwt. caffeine in regular caffeine consumers. 
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HOlO: There will be no difference between pre- and 
post-test scores on fingertip dexterity after consumption of 
0 mg/kg bwt. caffeine in regular caffeine consumers. 
HOll: There will be no difference between pre- and 
post-test scores on fingertip dexterity after consumption of 
2.5 mg/kg bwt. caffeine in regular caffeine consumers. 
H012: There will be no difference between pre- and 
post-test scores on fingertip dexterity after consumption of 
5.0 mg/kg bwt. caffeine in regular caffeine consumers. 
H013: There will be no difference between perceived 
ingestion of 0 mg/kg bwt., 2.5 mg/kg bwt., and 5.0 mg/kg 
bwt. caffeine in regular caffeine consumers. 
CHAPTER II 
REVIEW OF THE LITERATURE 
Introduction 
Recently, much attention has been directed toward 
caffeine and its properties as a possible ergogenic aid 
(27). Ergogenic aids are any substance or method that tend 
to increase the performance capacity of athletes. While the 
physiological and biochemical effects of caffeine have been 
reasonably well defined, the actual ergogenic effects are 
less clear. This is due mainly to the fact that many 
studies of caffeine and performance have had poor 
methodological controls (10). Current research has resulted 
in equivocal conclusions. 
The speculative physical effect of caffeine has 
prompted the International Olympic Committee and the 
National Collegiate Athletic Association of the u.s. to 
adopt bans on the use of caffeine to aid sport performance. 
Doses equivalent to 500-600 mg. caffeine or five to six cups 




Biological Effects of Caffeine 
Caffeine acts on almost every organ system in the 
body. Caffeine, the most potent methylxanthine, is a 
powerful CNS stimulant. It has prominent actions on the 
circulatory system. After therapeutic doses of caffeine 
peripheral vascular resistance declines. Vasodilation, 
coupled with cardiac output, results in increased blood 
flow. However, in man the increase in peripheral blood flow 
is short-lived. In contrast to caffeine's dilating effect 
on systemic blood vessels, it causes a marked increase in 
cerebrovascular resistance. Caffeine relaxes various smooth 
muscles other than those of blood vessels. Most 
importantly, caffeine acts to relax the smooth muscles of 
the bronchi, especially if the bronchi have been constricted 
by histamine or clinically in asthma. Caffeine augments the 
release of secretory products of a number of endocrine and 
exocrine tissues. Moderate oral doses of caffeine causes 
secretion of both stomach acid and pepsin. Caffeine also 
can increase the concentration of circulating catecholamines 
and can augment dopamine beta-hydroxylase and renin activity 
in the plasma in man. 
Three separate studies (28,29,30) found that caffeine 
did prolong endurance exercise bouts of one hour or more in 
competitive cyclists. The substrates that are used for fuel 
for endurance activities are mainly free fatty acids and 
muscle glycogen. The longer the muscle glycogen is spared, 
the greater the delay in the onset of exhaustion (29). 
Since caffeine ingestion increases plasma levels of free 
fatty acids, these substances are used as fuel and the 
muscle glycogen stores are not depleted as rapidly. 
Caffeine did not significantly improve performance during 
maximal short-term (anaerobic) exercise bouts (10). 
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Robertson, Frolich, and Carr (31) and Colton, Gosswlin, 
and Smith (32) have demonstrated that habitual caffeine 
users developed a tolerance to caffeine with respect to its 
effects on resting blood pressure and heart rate. Habitual 
caffeine users also have demonstrated tolerances to 
caffeine's effects on plasma and urinary catecholamines, 
(33) parotid gland secretion, (34) and it's sleep disturbing 
properties (35). 
Cornish and Christman (36) reported that 48 hours were 
needed to clear 66% of a 100 mg. caffeine dose. Axelrod and 
Reichenthal (11) stated that there was no day-to-day 
accumulation of the drug after a 500 mg. dose. 
Golstein et al. (35) was the first to document that 
heavy users became less jittery and nervous and had fewer 
headaches with high doses of caffeine. In the abstainers, 
caffeine produced jitteriness, nervousness, and 
gastrointestinal distress. 
Effects of Caffeine on Hand Steadiness 
and Manual Dexterity 
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The relationship between hand steadiness and the 
consumption of caffeine has intrigued researchers for a 
number of years. However, the results of such studies have 
had different outcomes. Caffeine, a phosphodiesterase 
inhibitor, has been shown to decrease tension and the degree 
of fusion of incomplete tetanic contractions of the cat and 
guinea pig soleus muscle (48,49). Bowmann and Nott have 
suggested further that such phosphodiesterase inhibitors, 
like beta-adrenoreceptor agonists, might enhance tremor in 
man. Some researchers have suggested that caffeine impairs 
hand steadiness and causes tremors (7,37,38,39). A 
psychologist, Hollingsworth, carefully devised nine double-
blind tests which he carried .out meticulously over a 40 day 
period. Most of his findings, including beneficial motor 
and mental effects from 65 to 130 mg. caffeine and tremor, 
poor motor performance, and insomnia caused by 390 mg. 
caffeine have been confirmed repeatedly over the past 60 
years (7). Hollingsworth (40) required subjects to hold a 
metal stylus in a hole without touching the sides. He 
observed a pronounced unsteadiness that reached its peak 
about 3 to 4 hours after the administration of 360 mg. 
caffeine. Other investigations have confirmed these 
results. Hull (41) found increased tremor after 300 mg. 
caffeine citrate. Steadiness was impaired also after 300 
mg. of caffeine sodium benzoate, or after a cup of coffee 
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(37). Adler (42) found increased hand tremor after 420 mg. 
of caffeine sodium benzoate. Lehmann and Csank (43) noted a 
significant decrease in steadiness after 600-900 mg. of 
caffeine citrate. Smith et al. (38) also found that 
caffeine exerted deleterious effects on hand steadiness and 
caused tremor. Winter (44) using caffeine naive subjects 
with a mean daily caffeine intake of 100 (± 74.6) mg. tested 
the effects of selected doses of caffeine following fasting 
on hand steadiness, tracing ability, kinesthetic sense, and 
manual dexterity. Each subject was tested on three 
occasions and received 0 milligrams per kilogram of body 
weight (mg/kg bwt.) caffeine, 2.5 mg/kg bwt. caffeine, and 
5.0 mg/kg bwt. caffeine. The experiment used a double-blind 
placebo controlled design. Subjects were pre-tested, 
administered an oral dose of caffeine randomly, and post-
tested each session. When recording data, hand steadiness 
was divided into error time and count. Tracing was divided 
also into total time of the completion of the task, error 
off time, and error count. The subjects fasted five hours 
prior to testing and fasted from caffeine 24 hours prior to 
testing. She found that hand steadiness time was 
significantly impaired (p~ 0.05) after the ingestion of 5.0 
mg/kg bwt. caffeine but not after 2.5 mg/kg bwt. Hand 
steadiness count was impaired significantly after 2.5 mg/kg 
bwt. and 5.0 mg/kg bwt. Tracing count was impaired signifi-
cantly after 5.0 mg/kg bwt. but not after 2.5 mg/kg bwt. 
Manual dexterity was impaired significantly after 5.0 mg/kg 
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bwt. but not after 2.5 mg/kg bwt. Tracing time, tracing off 
time, and kinesthetic sense were not affected significantly 
after any caffeine dose. 
In contrast, Wharrad, Birmingham, Macdonald, Inch, and 
Mead (45) indicated no finger tremor as a result of 150 mg. 
taken three times daily in conjunction with normal diet. 
Furthermore, Goldstein, Kaiser, and Warren (46) found no 
impairment of coordination as a result of 150 mg. and 300 
mg. of caffeine. Finally, Seashore and Ivy (47) reported no 
effect on steadiness, but their subjects were fatigued and 
this may account for the difference in results (39). 
Summary 
Currently no available investigations have explored the 
dose response curve as it applies to hand steadiness or 
manual dexterity in regular caffeine consumers. The results 
of studies regarding the effects of caffeine on hand 
steadiness and manual dexterity are inconsistent. These 
inconsistencies may be attributed to many variables 
including individual sensitivity to caffeine, differences in 
experimental protocol, differences in dose administrations, 
and in subject's previous caffeine consumption. It would be 
a valuable addition to literature to investigate the effects 
of caffeine on hand steadiness and manual dexterity in 




Eight healthy female volunteer subjects ranging in age 
from 20 to 26 that resided in a rural midwestern college 
town were used in this study. The subjects were volunteers 
and were chosen on the basis of availability. They do not 
represent a sample of a stratified group within the 
population. They were not chosen from a particular class or 
organization. The mean age of the subjects was 22.0 (± 2.1) 
years and the mean weight was 58.6 (± 8.5) kilograms. All 
subjects were briefed thoroughly on the scope of the study, 
informed of the nature and the procedures of the experiment, 
including any possible risks or ill effects of the ingested 
caffeine. After the subjects assured the investigators that 
they understood the purpose of the study, each subject read 
and signed an informed consent document as stipulated and 
approved by the Institutional Review Board at Oklahoma State 
University (Appendix A). The form was signed also by a 
witness (graduate student) and the principal investigator. 
All responses made by the subjects were held in strict 
confidence and filed with the principal investigator. 
As a precautionary measure, a physical screening and a 
23 
24 
medical history questionnaire were administered to each 
subject. The physical screening consisted of a pre-test 
blood pressure. Any subject exhibiting above 140 mm Hg 
systolic pressure and/or 95 mm Hg diastolic pressure and/or 
tachycardia was eliminated from the study. The medical 
history questionnaire (Appendix B) included questions 
pertaining to pregnancy, high blood pressure, current 
medication, cardiac or vascular disorders, and intestinal 
disorders. If any of the subjects indicated a positive 
response to the aforementioned symptoms prior to testing, 
they were eliminated from the study. Each subject also 
completed a caffeine consumption questionnaire which 
indicated the average amount of caffeine each subject 
ingested daily. Tolerance or non-tolerance then could be 
estimated from the subjects responses. 
Preliminary Procedures 
Prior to testing, the subjects were asked to fast from 
caffeine a minimum of 24 hours and from food a minimum of 
five hours. A 24 hour fast from caffeine was utilized to 
avoid a reduction in tolerance and to prevent residual 
caffeine from interfering with the study. After the 
necessary documents were completed and an explanation of the 
experiment was given, the subject's blood pressure was taken 
and recorded. 
Subjects were assigned randomly either a placebo or a 
caffeine dosage; 2.5 mg/kg bwt. or 5.0 mg/kg bwt. The 
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subject's body weight, which was determined by oral inquiry, 
was used to calculate the amount of caffeine in individual 
gelatin capsules. These dosages were prepared by a licensed 
pharmacist. Prior to each testing session each subject 
completed a caffeine update questionnaire (Appendix C) which 
determined if the subject was experiencing a lack of sleep, 
illness, a high level of stress, or pre-menstrual syndrome. 
If a subject indicated a positive response to any of the 
above questions she was given the opportunity to reschedule 
the test session. 
Equipment and Testing Procedure 
The study used a double-blind placebo controlled 
design. Neither the subject nor the principal investigator 
had knowledge of which dosage was ingested. In a 
counterbalanced design such as this, all subjects received 
all treatments (dosages) but in different order. The order 
in which the subjects received treatment (dosages) was 
determined randomly. Subjects also were randomly assigned 
to testing stations to avoid an order effect. Prior to the 
subject's ingestion of either the placebo or a caffeine 
dose, she was pre-tested on the following apparatus: 1) 
tracing pattern interfaced with an automatic timer and 
counter for hand steadiness, 2) Lafayette model 32001 
Steadiness tester (hole type, hole size 3 millimeters) with 
automatic timer and counter and hand held stylus, 3) 
kinesthesiometer used in conjunction with opaque goggles 
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which served as a blinder for kinesthetic sense, and 4) 
Lafayette O'Connor Dexterity tweezer-pin placement apparatus 
for fingertip dexterity and speed capacity of simple but 
rapid coordinated movement. Two time trials were recorded 
for each variable and then averaged with the exception of 
kinesthetic sense. Two variables were recorded when 
subjects were tested for hand steadiness. The first was 
hand steadiness time (HST) which was the amount of time (in 
seconds) during a 60 second test in which the subjects 
contacted the stylus with the plate. The second variable 
was hand steadiness count (HSC), which was the number of 
times during a 60 second time frame the subject contacted 
the plate with the stylus. 
Three variables were recorded for the tracing task. 
The first variable was total tracing time (TT), which was 
the total amount of time it took the subject to trace the 
pattern from start to finish. Secondly, tracing error (off) 
time (TOF) was recorded. This variable was the amount of 
time the subject was not in contact with the pattern. 
Lastly, tracing count (TC) was tested which indicated the 
number of times the subject was not in contact with the 
pattern. 
The value recorded when subjects were tested for 
kinesthetic sense (K) represented the difference between the 
correct angular position previously placed by the researcher 
and the angular placement by the subject in an attempt to 
duplicate the researcher's placement. The three angular 
displacements utilized were angles of 45, 30, and 60 
degrees. 
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The value that was recorded for manual dexterity (D) 
was the total amount of time it took the subjects to 
complete the first three rows of the tweezer-pin placement 
apparatus. The subjects started in the left hand corner and 
proceeded to fill the rows from left to right as quickly as 
possible. 
Subjects were assigned randomly to testing order and 
testing stations. Subjects were given identical verbal 
instructions for task completion at each testing station by 
the researcher. Two trials were recorded at each testing 
station with the exception of the kinesthesiometer which was 
recorded only once for each angle. 
After subjects were pre-tested at all four stations, 
they were administered an oral dose of either a placebo or 
2.5 mg/kg bwt. or 5.0 mg/kg bwt. caffeine. The placebo 
consisted of a gelatin capsule filled with lactose powder. 
Both placebo and caffeine doses were administered with cold 
tap water. Immediately after the caffeine was ingested, the 
time was recorded so that post-testing could be performed no 
less than one hour after ingestion. During the one hour 
waiting period, subjects were asked to relax and to refrain 
from food, beverages containing caffeine, and strenuous 
activity. 
Testing was conducted in a quiet isolated room with 
dividers between each station in an attempt to avoid any 
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outside visual or auditory distractions. All testing was 
performed in the Exercise Physiology lab on the Oklahoma 
State University campus. Pre- and post-test values were 
recorded for each one of the three dosages (Appendix E). 
Both time trials were averaged for pre-test and post-test 
scores. The mean of the two scores was determined for all 
pre-test and post-test data collected for each test of fine 
motor skill. 
Post Procedure 
Immediately following the post-test session each 
subject was asked to complete a perceived ingestion question 
to determine to amount of caffeine she believed she had 
consumed. It took approximately 1.5 hours to complete each 
testing session. The total time for all testing sessions 
was approximately 4.5 hours. Subjects were encouraged to 
eat immediately after the post-test session but were 
forewarned that the ingestion of spicy or greasy food could 
result in stomach upset or nausea. Any subject who had any 
ill feeling was instructed to contact the principal 
investigator immediately. 
CHAPTER IV 
RESULTS AND DISCUSSION 
Results 
This investigation involved the testing of seven 
hypotheses at a (alpha level) significance at the .05 level. 
A hypothesis for each of the following was tested: hand 
steadiness time, hand steadiness count, tracing time, 
tracing off time, tracing count, kinesthetic sense, and 
manual dexterity. The hypotheses were questioned to see if 
a difference occurred between post-tests when 0 mg/kg bwt., 
2.5 mg/kg bwt., and 5.0 mg/kg bwt. caffeine was ingested. 
Hypothesis 1-3 
The first three hypotheses stated there would be no 
difference between the placebo and two levels of caffeine 
post-tests on hand steadiness after consumption of placebo, 
2.5 mg/kg bwt. and 5.0 mg/kg bwt. caffeine in regular 
caffeine consumers. 
Hypothesis 4-6 
The fourth through sixth hypotheses stated there would 
be no difference between the placebo and two levels of 
caffeine post-tests on tracing after consumption of placebo, 
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The seventh through ninth hypotheses stated there would 
be no difference between the placebo and two levels of 
caffeine post-tests on the kinesthesiometer testing 
kinesthetic sense after consumption of placebo, 2.5 mg/kg 
bwt. and 5.0 mg/kg bwt. caffeine in regular caffeine 
consumers. 
Hypothesis 10-12 
The tenth through twelfth hypotheses stated there would 
be no difference between the placebo and two levels of 
caffeine post-tests on fingertip dexterity and speed 
capacity of simple but rapid coordinated movement after 
consumption of placebo, 2.5 mg/kg bwt. and 5.0 mg/kg bwt. 
caffeine in regular caffeine consumers. 
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The daily caffeine consumption of the subjects ranged 
between 320 and 573 mg. with a mean of 415 (± 96.5) mg. 
Although given the opportunity, no subject indicated a 
desire to reschedule any testing session due to a lack of 
sleep, an unusually high amount of stress, or any other item 
on the caffeine update questionnaire (Appendix C). The 
mean and standard deviations for each variable can be found 
in Table III. A 2 x 3 repeated measures analysis of 
variance (ANOVA) was performed for all variables with the 
three levels of administered doses (0 mg., 2.5 mg/kg bwt., 
and 5.0 mg/kg bwt.) serving as the grouping factor and the 
two-level trial factor consisting of the pre-test and post-
test measurements. This repeated measures analysis of 
variance was used in analyzing the pre-test data. No 
significance (p < .05) was found for any variable in the 
pre-test. A repeated measures analysis of variance also was 
used in analyzing post-test data and once again, no 
significance (p < .05) was found. Therefore all hypotheses 
failed to be rejected as no significance was found between 
post-tests on any variable. 
When subjects were administered the placebo the 
majority perceived to have ingested 0 mg/kg bwt. When 
subjects ingested 2.5 mg/kg bwt. caffeine (small dose) they 
perceived they had ingested a moderate amount. Lastly, when 
subjects ingested a moderate dose of 5.0 mg/kg bwt. caffeine 
they perceived to have ingested a moderate dose. In 
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conclusion, the author suggests that when subjects received 
a caffeine dose (not including placebo) they could not 
differentiate between a small dose and a moderate dose. 
Discussion of Results 
Based on the results of this investigation hand 
steadiness time, hand steadiness count, tracing time, 
tracing off time, kinesthetic sense, and manual dexterity 
are not impaired after the ingestion of 2.5 mg/kg bwt 
caffeine or 5.0 mg/kg bwt. caffeine. Therefore, the author 
suggests that those individuals who ingest large quantities 
of caffeine daily acquire a tolerance and the variables 
listed above are not significantly affected. 
In contrast to previous studies (7,37,38,39), the 
findings of this investigation are not consistent in that 
hand steadiness is not affected by caffeine. However, it 
is difficult to compare the results of this study to 
previous studies because in this study the dosages were 
given according to the subject's body weight (not a blanket 
dose which is often performed in caffeine research). Also, 
all subjects were female and well above the national average 
for caffeine consumption per day with a mean daily intake of 
415 (± 96.5) mg. per day. Subjects also were asked to fast 
from food five hours prior to testing and caffeine 24 hours 
prior to testing. It was not mentioned if these variables 
were considered in previous studies therefore making it 
difficult to make a comparison. 
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This study replicated the protocol of Winter's 
investigation (44) in regard to testing procedure and 
caffeine dosages. The major difference, however, was the 
fact that subjects in Winter's study were caffeine naive 
with a mean daily caffeine intake of 100 (± 74.6) mg. and 
the subjects who participated in this study were regular 
caffeine consumers with a mean daily caffeine intake of 415 
(± 96.5) mg. Winters found that fine motor skills were 
significantly impaired at 2.5 mg./kg. bwt. and 5.0 mg./kg. 
bwt. caffeine in caffeine naive subjects. However, regular 
caffeine consumers utilized in this study did not exhibit 
deleterious effects on fine motor skills after either 
caffeine dose. This lack of impairment on fine motor skills 
in subjects in this study is due to caffeine tolerance not 
exhibited by those in Winter's study. 
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TABLE II 
ANALYSIS OF VARIANCE 
HAND STEADINESS TIME 
Sum of D.F. Mean of F F 
Square Squares Ratio Prob. 
Condition 9.0149 2 4.50750 0.32 0.7283 
Error 194.57152 14 13.89797 
Time 9.99187 1 9.99187 1. 47 0.2647 
Error 47.58310 7 6.79759 
C X T 15.96501 2 7.98251 1. 93 0.1818 
Error 57.89496 14 4.13535 
HAND STEADINESS COUNT 
Sum of D.F Mean of F F 
Squares Squares Ratio Prob. 
Condition 2816.79167 2 1408.39583 1. 26 0.3131 
Error 15608.54167 14 1114.89583 
Time 2200.52083 1 2200.52083 2.22 0.1799 
Error 6940.64583 7 991.52083 
C X T 2959.54167 2 1479.77083 2.83 0.0927 
Time 7313.79167 14 522.41369 
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TABLE II (Continued) 
TRACING TIME 
Sum of D.F. Mean of F F 
Squares Squares Ratio Prob. 
Condition 1327.99879 2 663.99939 2.14 0.1547 
Error 4345.69634 14 310.40688 
Time 99.47522 1 99.47522 9.5 0.0177 
Error 73.26643 7 10.4663 
C X T 22.73288 2 11.36644 .32 0.7334 
Error 501.93046 14 35.85218 
TRACING OFF TIME 
Sum of D.F. Mean of F F 
Squares Squares Ratio Prob. 
Condition 10.71541 2 5.35771 0.77 0.4836 
Error 97.99459 14 6.99961 
Time 0.00083 1 0.00083 0.00 0.9745 
Error 5.31583 7 0.75940 
C X T 3.01292 2 1. 50646 1. 38 0.2827 
Error 15.23041 14 1.08789 
TRACING COUNT 
Sum of D.F. Mean of F F 
Squares Squares Ratio Prob. 
Condition 152.54167 2 76.27083 1.43 0.2732 
Error 749.12500 14 53.50893 
Time 16.33333 1 16.33333 1. 25 0.3001 
Error 91.33333 7 13.04762 
C X T 31.29167 2 15.64583 0.80 0.4679 
Error 273.04167 14 19.50298 
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TABLE II (Continued) 
KINESTHETIC SENSE 
Sum of D.F. Mean of F F 
Squares Squares Ratio Prob. 
Condition 16.16667 2 8.08333 1. 42 0.2750 
Error 79.83333 14 5.70238 
Time 0.33333 1 0.33333 0.08 0.7906 
Error 30.66667 7 4.38095 
C X T 7.16667 2 3.58333 1. 03 0.3834 
Error 48.83333 14 3.48810 
MANUAL DEXTERITY 
Sum of D.F. Mean of F F 
Squares Squares Ratio Prob. 
Condition 1279.89533 2 639.94766 1.24 0.3204 
Error 7248.13228 14 517.72373 
Time 322.40338 1 322.40338 1.09 0.3315 
Error 2073.67642 7 296.23949 
C X T 59.18781 2 29.59391 0.24 0.7930 
Error 1756.52249 14 125.46589 
TABLE III 
MEAN TIMES + STANDARD DEVIATIONS OF VARIABLES 
Group 
1. 0 mg./kg. bwt. 
2. 2.5 mg./kg. bwt. 
3. 5.0 mg./kg. bwt. 









HAND STEADINESS COUNT 
Group 
1. 0 mg./kg. bwt. 
2. 2.5 mg./kg. bwt. 
3. 5.0 mg./kg. bwt. 
Group 
1. 0 mg./kg. bwt. 
2. 2.5 mg./kg. bwt. 
3. 5.0 mg./kg. bwt. 
Group 
1. 0 mg./kg. bwt. 
2. 2.5 mg./kg. bwt. 




























TABLE III (Continued) 
Group 
1. 0 mg./kg. bwt. 
2. 2.5 mg./kg. bwt. 
3. 5.0 mg./kg. bwt. 
Group 
1. 0 mg./kg. bwt. 
2. 2.5 mg./kg. bwt. 
3. 5.0 mg./kg. bwt. 
Group 
1. 0 mg./kg. bwt. 
2. 2.5 mg./kg. bwt. 






























SUMMARY, CONCLUSIONS, AND RECOMMENDATIONS 
FOR FURTHER STUDY 
Summary 
Eight regular caffeine consuming females ranging in age 
from 20 to 26 were tested for the effects that selected 
doses of caffeine have on hand steadiness, tracing ability, 
kinesthetic sense, and manual dexterity. Each subject was 
tested three times and was administered either 0 mg/kg bwt., 
2.5 mg/kg bwt., or 5.0 mg/kg bwt. caffeine randomly. Each 
time a subject was tested a different dosage was 
administered. Subjects performed a pre-test prior to each 
ingestion. Approximately 60 minutes after the ingestion of 
either the placebo or caffeine dose a post-test was 
performed by each subject. 
Conclusions 
The findings of the study suggest that hand steadiness, 
tracing ability, kinesthetic sense, and manual dexterity are 
not impaired after ingestion of 2.5 mg/kg bwt. or 5.0 mg/kg 
bwt. in regular caffeine consuming subjects. Winter (44), 
in a previous study utilizing the same protocol as this 
study, found that hand steadiness time was impaired at 5.0 
39 
40 
mg/kg bwt. but not 2.5 mg/kg bwt. Secondly, hand steadiness 
count was impaired at both 2.5 and 5.0 mgjkg bwt. Also, 
tracing count was impaired at 5.0 mg/kg bwt. caffeine. 
Finally, manual dexterity was impaired at 5.0 mg/kg bwt. 
caffeine level but not 2.5 mg/kg bwt. caffeine level. 
However, subjects participating in Winter's study were 
caffeine naive and well below the national daily average of 
caffeine consumed which is 206 mg. (38). 
The findings of this study are consistent with previous 
studies regarding caffeinism in that individuals do indeed 
build up a tolerance to caffeine over an extended period of 
time. 
Recommendations for Further Study 
In an attempt to further study the effects of selected 
doses of caffeine the author suggests utilizing the same 
protocol in this study using more subjects and adding one 
more dosage higher than 5.0 mg/kg bwt. (ie. 7.5 mg/kg bwt.) 
in an attempt to identify a dose response curve and/or the 
saturation level in the subjects. Also, it would be 
interesting to utilize the protocol in Winter's study using 
caffeine naive subjects and add a caffeine dosage in between 
2.5 mg/kg. bwt. and 5.0 mg./kg. bwt. to identify at what 
point fine motor skills become impaired by caffeine. 
Another investigation which could benefit caffeine research 
would involve the testing of subjects on a full stomach. 
This study would attempt to determine if deleterious effects 
of caffeine are avoided, decreased, or delayed as a result 
of a full stomach. 
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Individual's Consent for Participation in a Research Project 
Oklahoma State University 
I, , voluntarily agree to participate 
in this study entitled: The Effects Caffeine on Hand 
Steadiness, Tracing Ability, Kinesthetic Sense and Manual 
Dexterity in Regular Caffeine Consumers. 
1. PURPOSE: This study involves research that will be 
carried out under the supervision of Bert H. Jacobson, Ed. 
D. and Stacy Renee' Thurman. The purpose of this study will 
be to ascertain the effects of 2.5 mg./kg. bwt. and 5.0 
mg./kg. bwt. caffeine on hand steadiness, tracing ability, 
kinesthetic sense, and manual dexterity. Such qualities are 
often necessary and I or vital for occupations today. Given 
that one cup of coffee contains 100 mg. caffeine, it is safe 
to assume that many professionals consume up to 400 mg. 
caffeine prior to or during work time. However, casual 
consumption is not all in one dose. This study will attempt 
to find if deleterious effects follow a single dose of 2.5 
mg./kg. bwt. and 5.0 mg./kg. bwt. caffeine consumption. 
2. STATUS ON INVESTIGATIONAL DRUG PROCEDURES: Caffeine may 
alter blood pressure, heart rate, respiration and metabolic 
rate. Caffeine may also induce tremors, nervousness, and 
anxiety. 
3. DESCRIPTION OF STUDY: This study will involve a 
prescreening consisting of blood pressure. Additionally a 
medical history questionnaire containing the following items 
will be administered: oral contraceptive use, medication 
use, current illnesses, pregnancy, hang over, and history of 
heart disease. Further, a caffeine consumption 
questionnaire will be administered to ascertain the average 
amount of caffeine consumed per day and week. Any subject 
indicating a blood pressure reading above 140 mm. Hg 
systolic pressure and/or 60 mm. Hg diastolic pressure and/or 
tachycardia will be eliminated from the study. Also, any 
positive response on the medical history questionnaire will 
result in elimination. 
Subjects will be asked to fast from food for 5 hours 
and fast from caffeine for 24 hours prior to testing. 
Subjects will be pre-tested for hand steadiness, tracing 
ability, kinesthetic sense, and manual dexterity. Following 
the pre-test, each subject will be given on of three 
solutions containing 1) 0 mg. caffeine, 2) 2.5 mg./kg. bwt. 
or 3) 5.0 mg./kg. bwt. caffeine on a double blind format. 
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Following a one (1) hour waiting period, all subjects will 
be post-tested using the pre-test protocol. The full 
duration of this study will take approximately one and a 
half (1.5) hours. 
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I understand that I will be given 0 mg., 2.5 mg./kg. 
bwt. and 5.0 mg./kg. bwt. caffeine. Neither I nor the 
investigator will know which dosage I have been administered 
during each test but that information can be obtained if 
necessary. 
4. BENEFITS: No direct benefit in the consumption of 
caffeine may be expected. However, observable physical 
changes may lead to a change in attitude toward caffeine 
consumption and a greater awareness of products containing 
caffeine may ensue. 
5. POSSIBLE RISKS: Caffeine ingestion in the quantities 
described in this study may increase nervousness, 
irritability and anxiety. Respiration, blood pressure and 
heart rate may also be magnified. Additionally, nausea may 
appear if the meal following caffeine consumption includes 
spicy and/or greasy food. STAY AWAY FROM PIZZA! If you 
become nauseous or feel ill, you will be retained for 
observation and transported to the University Health Center. 
I recognize that the primary risk is the possibility of 
experiencing some side effects. Those that have been 
observed in the past for caffeine consumption include: 
Hyperactivity 
Upset stomach after eating pizza 
If I have any side-effects, I will report them immediately 
to the investigator, my physician or his/her associates. If 
side-effects are severe, I may be removed from the study. 
6. ALTERNATE PROCEDURES: None 
7. SUBJECT ASSURANCES: Whereas no assurance can be made 
concerning results that may be obtained (because results 
from investigational studies cannot be predicted with 
certainty), the principal investigator will take every 
precaution consistent with best scientific practice. 
By signing this consent form, I acknowledge that my 
participation in this study is voluntary. I also 
acknowledge that I have not waived any of my legal rights or 
released this institution from liability for negligence. 
I may revoke my consent and withdraw from this study at 
any time without penalty or loss of benefits. My treatment 
by, and relations with the investigators and staff at 
Oklahoma State University, now and in the future, will not 
be affected in any way if I refuse to participate, or if I 
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enter the program and later withdraw. 
Records of this study will be kept confidential with 
respect to any written or verbal reports making it 
impossible to identify me individually. All records will be 
held in a locked file belonging to the PI. 
If I have any questions about my rights as a research 
subject, I may take them to the office of University 
Research Services, 001 Life Sciences East. Phone: 744-9991. 
8. SIGNATURES: 
Date Research Subject 
Date Witness 
Date Principal Investigator 
Any questions regarding the research may be addressed 
to Bert Jacobson, 102 Colvin Center. Phone: 744-5493. 
Subjects will receive a copy of this consent form following 
the study. 
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CAFFEINE RESEARCH QUESTIONNAIRE 
Caffeine Consumption History 
Vital Statistics 
Medical History 
Name ______________________ ___ Age __ _ Weight ___ _ 
Height ___ _ Pre BP: ------------
Caffeine Consumption History 
Coffee: Cups/day average 
Soft drinks: (Coke, Pepsi, Diet Coke, etc.)/day ________ _ 
Tea: Cups/day ___ _ Glasses/day __________ _ 
Other: Explain __________________________________________ _ 
How does caffeine affect you? ____________________________ _ 
Medical History 
Have you ever experienced or know of: 
Heart trouble Stomach disorders --------Intestinal disorders High blood pressure __ _ 
High heart rate Mental/emotion. dis. __ _ 
Are you presently on medication? 
Are you suffering from a hangover? 
Do you think you are pregnant? 
Are you currently taking oral contraceptives? ________ _ 
Are you currently suffering from lack of sleep? 
Have you fasted for five hours? 
Last meal was hours ago. 
Last caffeine was consumed 
Time of ingestion 
Time of testing 
Group 
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hours ago in the form of 
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CAFFEINE RESEARCH QUESTIONNAIRE UPDATE 
Caffeine Consumption Update 
Vital Statistics 
Medical Update 
Name ________________________ ___ Session ------------
Pre BP ______________________ __ Post BP ------------
1. Are you presently on medication? If so, what? 
2. Are you suffering from a hangover? ____________ _ 
3. Do you think you are pregnant? ________________ _ 
4. Are you taking oral contraceptives? __________ __ 
5. Are you suffering from lack of sleep? ________ __ 
6. Are you currently experiencing a high level of stress? 
If so, would you prefer to reschedule this session? ____ _ 
7. Are you currently experiencing PMS? ____ If so, would 
you like to reschedule this session? ____ _ 
8. Have you suffered an illness since your previous test 
session?(flu, cold, etc.) If so, what? __________________ _ 
9. Has your average caffeine consumption per day changed 
since you previous test session? If so, what is 
it? --------------------------------------------------------
Have you fasted from food for five hours? -----------------
Your last meal was hours ago? 
Your last caffeine was consumed 
form of -------------------------------------
Time of ingestion 
Time of testing 
Group 
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hours ago in the 
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INSTRUCTIONS FOR TESTING 
INSTRUCTIONS FOR HAND STEADINESS 
1. Hold stylus like you would a pencil. 
2. Do not rest fingers or arm on table or brace arm against 
your body in any way. 
3. Hold tip of stylus in hole which has two black stripes 
above it. 
4. You will perform this test for 60 seconds. 
5. Every time you touch the sides a buzzer will sound. Do 
not be alarmed by it. 
INSTRUCTIONS FOR TRACING 
1. Hold stylus as you would a pencil. 
2. Do not rest or brace fingers or arm on table. 
3. Trace the pattern on the board, working from the bottom 
of the pattern to the top. 
4. This is not a race for time. 
5. The stylus should remain in contact with the pattern at 
all times. Do not lift the stylus from the board and 
try to replace it if you move off the pattern. 
INSTRUCTIONS FOR KINESTHETIC SENSE 
1. Place the blindfold on your head. 
2. Place your right arm in the tray. 
3. Grasp knob with your little finger. 
4. The tester will move your arm to a designated spot and 
back to the point of origin. 
5. With your eyes closed you will attempt to move your arm 
to the exact point the tester did and stop at that 
position. 
INSTRUCTIONS FOR MANUAL DEXTERITY 
1. Hold the tweezers with your thumb and forefinger with 
your palm surface on top of the tweezers. 
2. Using the tweezers, pick up a pin from the bowl and 
place it in the first row, first hole on the left side. 
3. Work from left to right. When you complete the first 
row move to the second and complete it as you did the 
first. You are to fill the first three rows. 




RAW DATA RECORD SHEET 
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RAW DATA RECORD SHEET 
Name Session --------------------------- --------------------
PRE POST 
Hand Steadiness (60 sec) Hand Steadiness (60 sec) 




Total Time Off Time Count Total Time Off Time Count 
1. 1. 
2. 2 . 
Kinesthesiometer Kinesthesiometer 
1. (45) 1. (45) 
2. (30) 2. ( 30) 
3. (60) 3 . ( 60) 
O'Connor Dexterity O'Connor Dexterity 
1. 1. 
2 • 2. 
Perceived Ingestion 
None Small Moderate Large 
0 
Place an X at the point you feel most indicates your 




POST TEST RAW DATA 
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POST TEST RAW DATA 
0.0 mg./kg. bwt caffeine 
Subject HST HSC TT TOF TC K D 
1 04.5 099 40.5 02.5 17 01 098.9 
2 03.1 027 13.1 02.3 17 04 082.7 
3 04.4 065 33.8 03.8 18 03 077.5 
4 01.0 028 61.4 02.3 18 05 091.7 
5 21.6 144 33.9 06.2 31 04 116.0 
6 04.5 049 16.6 10.9 20 02 170.0 
7 02.3 046 20.7 02.6 16 04 082.8 
8 06.6 074 31.8 02.3 08 05 072.1 
2.5 mg./kg. bwt. caffeine 
1 04.8 112 35.6 05.5 28 03 086.1 
2 04.2 053 16.8 02.4 15 04 111.6 
3 08.5 117 34.6 05.5 34 07 081.0 
4 02.0 068 04.3 00.8 21 05 081.5 
5 07.4 098 20.2 02.7 25 11 155.7 
6 07.4 071 12.0 07.8 14 06 209.3 
7 00.7 015 12.5 02.2 21 05 071.0 











POST TEST RAW DATA (Cont.) 
5.0 mg./kg. bwt. caffeine 
HSC TT TOF TC 
115 39.4 06.2 24 
101 13.6 03.8 24 
093 33.6 04.0 18 
178 55.3 07.0 21 
100 28.7 04.8 28 
053 23.7 07.6 27 
049 18.6 02.2 23 












MEANS OF PRE AND POST TEST DATA FOR 
EACH CAFFEINE DOSE 
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MEANS OF PRE AND POST TEST DATA FOR EACH CAFFEINE DOSE 
2.5 mg./kg. bwt. caffeine 
PRE POST 
HAND STEADINESS TIME 4.98 5.38 
HAND STEADINESS COUNT 61.63 78.13 
TRACING TIME 22.34 20.48 
TRACING OFF TIME 3.74 3.55 
TRACING COUNT 18.75 21.63 
KINESTHETIC SENSE 4.38 5.63 
MANUAL DEXTERITY 114.11 109.88 
5.0 mg./kg. bwt. caffeine 
PRE POST 
HAND STEADINESS TIME 4.86 7.36 
HAND STEADINESS COUNT 70.63 101.75 
TRACING TIME 35.09 30.26 
TRACING OFF TIME 4.45 5.13 
TRACING COUNT 22.13 23.75 
KINESTHETIC SENSE 4.88 4.38 
MANUAL DEXTERITY 116.85 113.79 
64 
Stacy Renee' Thurman 
Candidate for the Degree of 
Master of Science 
Thesis: THE EFFECTS OF CAFFEINE ON HAND STEADINESS, 
TRACING ABILITY, KINESTHETIC SENSE, AND MANUAL 
DEXTERITY IN REGULAR CAFFEINE CONSUMERS 
Major Field: Health, Physical Education, and Recreation 
Biographical: 
Personal Data: Born in Starkville, Mississippi, July 
15, 1966, the daughter of Dr. and Mrs. Charles W. 
Thurman. 
Education: Graduated from Perkins-Tryon High School, 
Perkins, Oklahoma, in May 1984; received Bachelor 
of Science Degree from Oklahoma State University 
in May, 1989; completed requirements for the 
Master of Science degree at Oklahoma State 
University in May 1991. 
